Also trades as: 4553.T (JPX) · $vol 3M

$25.98

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · $1.3B mcap · 23M float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$275.4B +6.1% ▲

5Y CAGR: +12.2%

Gross Profit

$99.7B +5.3% ▲

5Y CAGR: +8.8%

Operating Income

$23.2B +0.0% ▲

5Y CAGR: +3.1%

Net Income

$5.3B -72.2% ▼

5Y CAGR: -17.7%

EPS (Diluted)

$107.05 -72.2% ▼

5Y CAGR: -17.0%

EBITDA

$46.2B -3.8% ▼

5Y CAGR: +8.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$165.6B	$208.9B	$227.9B	$259.6B	$275.4B
YoY Growth	+6.9%	+26.1%	+9.1%	+13.9%	+6.1%
Cost of Revenue	$95.4B	$136.1B	$146.6B	$164.9B	$175.7B
Gross Profit	$70.2B	$72.7B	$81.4B	$94.7B	$99.7B
Gross Margin	42.4%	34.8%	35.7%	36.5%	36.2%
R&D Expenses	$11.5B	$15.3B	$13.2B	$0	$0
SG&A Expenses	$40.2B	$51.9B	$50.5B	$71.5B	$76.5B
Operating Expenses	$51.0B	$67.2B	$63.7B	$71.5B	$76.5B
Operating Income	$19.2B	$5.5B	$17.6B	$23.2B	$23.2B
Operating Margin	11.6%	2.6%	7.7%	9.0%	8.4%
Interest Expense	$230M	$635M	$947M	$1.6B	$2.3B
Income Before Tax	$22.2B	$4.6B	$24.5B	$26.3B	$13.2B
Tax Expense	$6.3B	$2.4B	$8.3B	$7.3B	$8.0B
Net Income	$15.9B	$2.2B	$16.2B	$19.0B	$5.3B
Net Margin	9.6%	1.1%	7.1%	7.3%	1.9%
EPS (Diluted)	$316.19	$44.72	$328.59	$385.71	$107.05
EBITDA	$29.5B	$24.9B	$43.3B	$48.1B	$46.2B
Shares Outstanding	50M	50M	49M	49M	49M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$62.6B	$60.8B	$70.3B	$65.9B	$65.1B	$66.3B	$73.7B	$70.1B
Cost of Revenue	$39.2B	$39.3B	$44.5B	$41.9B	$41.5B	$42.4B	$45.7B	$45.9B
Gross Profit	$23.3B	$21.6B	$25.8B	$24.0B	$23.7B	$23.9B	$27.9B	$24.1B
Gross Margin	37.3%	35.5%	36.7%	36.4%	36.3%	36.0%	37.9%	34.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$17.7B	$16.7B	$18.7B	$18.4B	$18.5B	$18.6B	$18.9B	$20.5B
Operating Expenses	$17.7B	$16.7B	$17.7B	$19.4B	$18.5B	$18.6B	$18.9B	$20.5B
Operating Income	$5.7B	$4.8B	$8.1B	$4.6B	$5.2B	$5.3B	$9.1B	$3.6B
Operating Margin	9.1%	8.0%	11.5%	7.0%	8.0%	8.0%	12.3%	5.2%
Interest Expense	$269M	$384M	$332M	$410M	$473M	$618M	$532M	$584M
Income Before Tax	$8.6B	$1.7B	$11.5B	$4.5B	$4.0B	$8.1B	$12.0B	-$10.9B
Tax Expense	$3.1B	$655M	$3.5B	$136M	$1.4B	$2.3B	$3.1B	$1.1B
Net Income	$5.5B	$1.1B	$8.1B	$4.4B	$2.5B	$5.8B	$8.9B	-$11.9B
Net Margin	8.8%	1.7%	11.5%	6.6%	3.9%	8.7%	12.1%	-17.0%
EPS (Diluted)	$111.64	$21.53	$163.92	$88.61	$51.05	$117.00	$180.38	$-241.27
EBITDA	$10.4B	$9.7B	$12.3B	$11.0B	$10.5B	$14.5B	$14.9B	$9.7B
Shares Outstanding	49M	49M	49M	49M	49M	49M	49M	49M

TWAPF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet